Introduction: Why Late-Phase Bioanalysis Requires a Different Approach As a clinical development program progresses into Phase II and Phase III, […]
Bioanalytical CRO Services for Phase II and Phase III Clinical Trials Read More »
Introduction: Native Mass Spectrometry for Biosimilars has emerged as a highly advanced analytical strategy for investigating the quaternary structure and
Native Mass Spectrometry for Biosimilars: Studying Protein Structure and Complexes Read More »
Introduction: When the Synthesis Route Itself Becomes the Problem The pharmaceutical industry’s encounter with nitrosamine contamination has revealed an important
Introduction Understanding What Are Nitrosamines is essential when evaluating the chemical safety, purity, and structural stability of raw materials, water
What Are Nitrosamines? Formation Mechanisms, Types, and Health Risks Explained Read More »
Introduction: The Real Test of a Bioanalytical Method Begins After Validation Method validation confirms that a bioanalytical method performs reliably
Primary Regulatory and Technical Challenges in Combination Device Development Chemical migration assessment for drug-device combination systems plays a central role
Introduction: Why EMA vs FDA Bioanalytical Method Validation Differences Matter Understanding EMA vs FDA Bioanalytical Method Validation Differences is extremely
EMA vs FDA Bioanalytical Method Validation: Key Regulatory Differences Explained Read More »
Introduction: A reliable peptide purity testing report should provide a complete analytical overview that confirms peptide identity, purity, composition, and
Common Reasons Biosimilars Fail Analytical Comparability (and How to Fix Them) Read More »
Introduction: The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use released the ICH M10 Bioanalytical Method
ICH M10 Bioanalytical Method Validation Guidelines: What Drug Developers Need to Know Read More »
Introduction: Why Critical Quality Attributes (CQAs) in Biosimilars Need Advanced Analysis The evaluation of Critical Quality Attributes (CQAs) in Biosimilars
